Compare NMM & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMM | HTFL |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2007 | 2025 |
| Metric | NMM | HTFL |
|---|---|---|
| Price | $88.56 | $49.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $85.00 | $38.20 |
| AVG Volume (30 Days) | 108.4K | ★ 1.8M |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | ★ 0.34% | N/A |
| EPS Growth | N/A | ★ 82.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,034,000.00 |
| Revenue This Year | $5.57 | $27.66 |
| Revenue Next Year | $3.66 | $23.55 |
| P/E Ratio | $7.24 | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $43.02 | $20.13 |
| 52 Week High | $87.66 | $47.95 |
| Indicator | NMM | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 77.31 | 88.58 |
| Support Level | $69.21 | $24.59 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.14 | 2.39 |
| MACD | 0.62 | 2.31 |
| Stochastic Oscillator | 90.13 | 98.08 |
Navios Maritime Partners LP is an international owner and operator of dry cargo and tanker vessels. Its vessels are generally chartered-out under short-term, medium-term and long-term time charters with an average remaining charter duration of approximately 2.1 years to a group of counterparties. Its fleet consisted of dry bulk vessels, containerships and tanker vessels, including two newbuilding capesize vessels, newbuilding containerships and newbuilding tankers. It operates in single segment.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.